Translational research platforms integrating clinical and omics data: a review of publicly available solutions

Abstract

The rise of personalized medicine and the availability of high-throughput molecular analyses in the context of clinical care have increased the need for adequate tools for translational researchers to manage and explore these data. We reviewed the biomedical literature for translational platforms allowing the management and exploration of clinical and omics data, and identified seven platforms: BRISK, caTRIP, cBio Cancer Portal, G-DOC, iCOD, iDASH and tranSMART. We analyzed these platforms along seven major axes. (1) The community axis regrouped information regarding initiators and funders of the project, as well as availability status and references. (2) We regrouped under the information content axis the nature of the clinical and omics data handled by each system. (3) The privacy management environment axis encompassed functionalities allowing control over data privacy. (4) In the analysis support axis, we detailed the analytical and statistical tools provided by the platforms. We also explored (5) interoperability support and (6) system requirements. The final axis (7) platform support listed the availability of documentation and installation procedures. A large heterogeneity was observed in regard to the capability to manage phenotype information in addition to omics data, their security and interoperability features. The analytical and visualization features strongly depend on the considered platform. Similarly, the availability of the systems is variable. This review aims at providing the reader with the background to choose the platform best suited to their needs. To conclude, we discuss the desiderata for optimal translational research platforms, in terms of privacy, interoperability and technical features.

Rise of Microbial Culturomics: Noncontiguous Finished Genome Sequence and Description ofBeduini massiliensisgen. nov., sp. nov.

“…New biotechnologies and omics methodologies are intensively being developed in the postgenomics era as we traverse the complex space between structure and function, within and across species and microorganisms, in the course of integrative biology research (Adams et al, 2013;Akondi and Lakshmi, 2013;Canuel et al, 2015;Singh et al, 2013). The assessment of the human gut microbiota is one of these emerging omics frontiers and is in need of new methodological approaches.…”

Intelligence artificielle appliquée à la radiothérapie

“…Concernant spé-cifiquement la radiothérapie, la qualité des données générées est meilleure que dans la majorité des autres champs de la méde-cine. Grâce aux systèmes de record and verify, les données sur les variabilités de positionnement et les éventuelles déviations au traitement prescrit sont enregistrées de faç on prospective, ce qui [38]. Malgré les avancées technologiques, certains auteurs estiment que la quantité de données générées dépassera bientôt les capacités de stockage des institutions.…”

Ontologies appliquées biomédicales et ontologie philosophique : un développement complémentaire

“…Elles ont notamment pris une importance croissante dans les sciences biologiques ainsi que dans la recherche et la pratique médi-cales 2 : il importe en effet que l'information contenue dans les ouvrages biomédicaux, journaux et essais cliniques soit vraiment accessible et utilisable par les praticiens et les chercheurs du domaine (Burgun et Bodenreider 2008). Un des enjeux majeurs de l'interopérabilité des données dans le domaine biomédical est le développement de la médecine personnalisée, qui consiste en l'adaptation des pratiques mé-dicales et des décisions thérapeutiques aux spécificités des patients (Canuel et al 2014).…”